Biologics in systemic lupus erythematosus: current options and future perspectives

被引：6
|
作者：
Yusof, Yuzaiful Md [1 ,2 ]
Vital, Edward M. [1 ,2 ]
Emery, Paul [1 ,2 ]
机构：
[1] Univ Leeds, Chapel Allerton Hosp, Leeds Inst Rheumat & Musculoskeletal Med, Leeds LS7 4SA, W Yorkshire, England
[2] Leeds Teaching Hosp NHS Trust, NIHR Leeds Musculoskeletal Biomed Res Unit, Leeds, W Yorkshire, England
来源：
BRITISH JOURNAL OF HOSPITAL MEDICINE | 2014年 / 75卷 / 08期
关键词：
B-LYMPHOCYTE STIMULATOR; DOUBLE-BLIND; DISEASE-ACTIVITY; PHASE-III; EFFICACY; SAFETY; NEPHRITIS; RITUXIMAB; BELIMUMAB; MANIFESTATIONS;
D O I：
10.12968/hmed.2014.75.8.440
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：440 / 447
页数：8
相关论文
共 50 条
  • [41] Anxiety and Mood Disorders in Systemic Lupus Erythematosus: Current Insights and Future Directions
    Tisseverasinghe, Annaliese
    Peschken, Christine
    Hitchon, Carol
    CURRENT RHEUMATOLOGY REPORTS, 2018, 20 (12)
  • [42] Cognitive dysfunction in pediatric systemic lupus erythematosus: current knowledge and future directions
    Kammeyer, Ryan
    Ogbu, Ekemini A.
    Cooper, Jennifer C.
    Stolz, Erin
    Piquet, Amanda L.
    Fuhlbrigge, Robert C.
    Bennett, Jeffrey L.
    Hutaff-Lee, Christa
    CHILD NEUROPSYCHOLOGY, 2024, 30 (05) : 818 - 846
  • [43] Pulmonary Arterial Hypertension in Systemic Lupus Erythematosus: Current Status and Future Direction
    Dhala, Atiya
    CLINICAL & DEVELOPMENTAL IMMUNOLOGY, 2012,
  • [44] The Type 1 & 2 systemic lupus erythematosus model: Perspectives of people living with systemic lupus erythematosus
    Eudy, Amanda M.
    Clowse, Megan E. B.
    Corneli, Amy
    Mckenna, Kevin
    Pisetsky, David S.
    Maheswaranathan, Mithu
    Burshell, Dana
    Doss, Jayanth
    Sun, Kai
    Sadun, Rebecca E.
    Criscione-Schreiber, Lisa G.
    Rogers, Jennifer L.
    LUPUS, 2024, 33 (03) : 266 - 272
  • [45] Therapy of systemic lupus erythematosus: a look into the future
    Smolen, Josef S.
    ARTHRITIS RESEARCH & THERAPY, 2002, 4 (Suppl 3) : S25 - S30
  • [46] Systemic lupus erythematosus: Future therapeutic avenues
    Amoura, Z.
    Haroche, J.
    Piette, J. -C.
    REVUE DE MEDECINE INTERNE, 2008, 29 (09): : 718 - 724
  • [47] Therapy of systemic lupus erythematosus: a look into the future
    Josef S Smolen
    Arthritis Research & Therapy, 4
  • [48] International and multidisciplinary expert recommendations for the use of biologics in systemic lupus erythematosus
    Kleinmann, Jean-Francois
    Tubach, Florence
    Le Guern, Veronique
    Mathian, Alexis
    Richez, Christophe
    Saadoun, David
    Sacre, Karim
    Sellam, Jeremie
    Seror, Raphaele
    Amoura, Zahir
    Andres, Emmanuel
    Audia, Sylvain
    Bader-Meunier, Brigitte
    Blaison, Gilles
    Bonnotte, Bernard
    Cacoub, Patrice
    Caillard, Sophie
    Chiche, Laurent
    Chosidow, Olivier
    Costedoat-Chalumeau, Nathalie
    Daien, Claire
    Daugas, Eric
    Derdeche, Nairouz
    Doria, Andrea
    Fain, Olivier
    Fakhouri, Fadi
    Farge, Dominique
    Gabay, Cem
    Guillo, Sylvie
    Hachulla, Eric
    Hajjaj-Hassouni, Najia
    Hamidou, Mohamed
    Houssiau, Frederic A.
    Jourde-Chiche, Noemie
    Kone-Paut, Isabelle
    Ladjouz-Rezig, Aicha
    Lambotte, Olivier
    Lipsker, Dan
    Mariette, Xavier
    Martin-Silva, Nicolas
    Martin, Thierry
    Maurier, Francois
    Meckenstock, Roderich
    Mekinian, Arsene
    Meyer, Olivier
    Mohamed, Shirine
    Morel, Jacques
    Moulin, Bruno
    Mulleman, Denis
    Papo, Thomas
    AUTOIMMUNITY REVIEWS, 2017, 16 (06) : 650 - 657
  • [49] Current role of rituximab in systemic lupus erythematosus
    Mok, Chi Chiu
    INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2015, 18 (02) : 154 - 163
  • [50] Current Trends in the Treatment of Systemic Lupus Erythematosus
    Raja, Tharsius W.
    Veeramuthu, Duraipandiyan
    Savarimuthu, Ignacimuthu
    Al-Dhabi, Naif A.
    CURRENT PHARMACEUTICAL DESIGN, 2020, 26 (22) : 2602 - 2609
12345